The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation

BACKGROUND: This study aimed to analyze associations between genetic variants and plasma concentrations along with clinical outcomes in dabigatran in patients with non-valvular atrial fibrillation (NVAF). METHODS: We conducted a prospective study and enrolled NVAF patients treated with dabigatran in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhu, Qian, Chenyue, Su, Cunjing, Tao, Hong, Mao, Jiaojiao, Guo, Zhening, Zhu, Xinyi, Pan, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652877/
https://www.ncbi.nlm.nih.gov/pubmed/36368930
http://dx.doi.org/10.1186/s12872-022-02910-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652877/
https://www.ncbi.nlm.nih.gov/pubmed/36368930
http://dx.doi.org/10.1186/s12872-022-02910-4

Ejemplares similares